Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 20;16(2):e54569.
doi: 10.7759/cureus.54569. eCollection 2024 Feb.

The Role of Gut Microbiome in the Pathogenesis and the Treatment of Inflammatory Bowel Diseases

Affiliations
Review

The Role of Gut Microbiome in the Pathogenesis and the Treatment of Inflammatory Bowel Diseases

Andrea Vidal-Gallardo et al. Cureus. .

Abstract

Inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, is a chronic condition characterized by inflammation of the gastrointestinal tract. Its exact cause is unknown, but it's thought to result from a dysregulated immune response influenced by various factors, including changes in the intestinal microbiota, diet, lifestyle, and genetics. The gut microbiome, consisting of diverse microorganisms, plays a crucial role in maintaining physiological balance, with its disruption leading to inflammatory responses typical of IBD. Treatments primarily aim at symptom control, employing immunomodulators, corticosteroids, and newer approaches like probiotics, prebiotics, fecal transplants, and dietary modifications, all focusing on leveraging the microbiota's potential in disease management. These strategies aim to restore the delicate balance of the gut microbiome, typically altered in IBD, marked by a decrease in beneficial bacteria and an increase in harmful pathogens. This review underscores the importance of the gut microbiome in the pathogenesis and treatment of IBD, highlighting the shift towards personalized medicine and the necessity for further research in understanding the complex interactions between the gut microbiota, immune system, and genetics in IBD. It points to the potential of emerging treatments and the importance of a multifaceted approach in managing this complex and challenging disease.

Keywords: gut microbiome; ibd; immune dysregulation; inflammatory bowel disease; treatment strategies.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Dysbiosis as a main trigger for IBD
1 - Physiological homeostasis. 2 - Disruption of homeostasis leads to a state of "intestinal dysbiosis. 3 - Dysbiosis combined with various factors triggers inflammatory signaling mechanisms. 4 - Leading to inadequate immune responses and the production of cytokines and inflammatory mediators. 5 - The resultant persistent inflammatory environment is a hallmark of IBD [22]. IBD: Inflammatory bowel disease Image Credits: Luis Fernando Ochoa Meza

Similar articles

Cited by

References

    1. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Ng SC, Shi HY, Hamidi N, et al. Lancet. 2017;390:2769–2778. - PubMed
    1. Assessing the relationship between the gut microbiota and inflammatory bowel disease therapeutics: a systematic review. Mah C, Jayawardana T, Leong G, et al. Pathogens. 2023;12 - PMC - PubMed
    1. Epidemiology of inflammatory bowel disease in South America: a systematic review. Selvaratnam S, Gullino S, Shim L, Lee E, Lee A, Paramsothy S, Leong RW. World J Gastroenterol. 2019;25:6866–6875. - PMC - PubMed
    1. Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: a systematic review and meta-analysis. Gandhi A, Shah A, Jones MP, Koloski N, Talley NJ, Morrison M, Holtmann G. Gut Microbes. 2021;13:1933313. - PMC - PubMed
    1. Epidemiology, disease burden, and treatment challenges of ulcerative colitis in Africa and the Middle East. Sharara AI, Al Awadhi S, Alharbi O, et al. Expert Rev Gastroenterol Hepatol. 2018;12:883–897. - PubMed

LinkOut - more resources